Explore

Innovations

Published

Healthcare & Pharmaceuticals

Inhibitors Against SARS-CoV-2

Researchers at UArizona have developed inhibitors for two cysteine proteases that are encoded by SARS-CoV-2: the main protease (Mpro) and the papain-like protease (PLpro).

By The University of Arizona

Published

Healthcare & Pharmaceuticals

Inhibitors Targeting COVID-19

This technology encompasses the development of novel inhibitors for the main protease of SARS-CoV-2.

By The University of Arizona

Do you have an innovative technology, product or service?

Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.

View all

Content Hub

Published

Neutrophil elastase inhibitor for the treatment of inflammatory lung diseases

Single-domain antibody inhibiting human neutrophil elastase

By Yasmina ZEROUAL, University of Liège

Published

Development of MurJ and FtsW inhibitors to treat antimicrobial resistance

Method based on fluorescence anisotropy to measure MurJ and FtsW activities

By Yasmina ZEROUAL, University of Liège

Share your thoughts, insights and tips

Join thousands of like-minded individuals from across the globe to share your insight on fresh innovative topics by posting articles.

View all